NEW PR : IMMUNE Pharmaceuticals' Oncology subsidiary, CYTOVIA, announces the filing of a world-wide patent protecting the use of Ceplene® in acute myeloid leukemia (AML) and other hematological cancers with mutated NPM1 (beQuoted) 2017-07-13 08:27 ( swedish time )
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.